Ayman et al. claimed that interleukin 6 (IL-6), a well-known marker of inflammation, has a significant positive association with SCD risk even following adjustment for two main SCD risk factors, including incident myocardial infarction and heart failure [36]. This evidence concerns the gene IL6 and heart failure.